The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Can be but my advice is let this baby do its thing. I'm happy to hold till end of next year or so. Derisked half of my holding previous days because it was a little bit overstretched in my portfolio. But the remaining saldo is for the LT.
I had 22.5p in my mind before the delay and the current turmoil. If we can reach 18.5p now I'm happy. This for the short term. In the long run we should move much higher imo.
I think Avion submits a plan of procedure and then it's up to the FDA. Discussions, what is the hart of a SPA, will then eventually lead to an accepted protocol. Or not if they don't come to an agreement.
From a traders view it would be good to go a bit higher before the news comes in. Then mid twenties must be possible imo. Of course if it is damned good news.
I don't think the FDA put forward programs, they only have their guidelines on which they decide. In the case of Lupuzor, Avion has come up with a new way of defining endpoints and that will be certainly food for discussion.